The nation of Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's request for sensitive data.
This rejection became public following a official document dated December was disclosed, which showed President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
An official spokesman later explained that the US was seeking genetic material for scientific study and commercial gain but was unwilling to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for further dialogue to reach a deal suitable to all parties so the nation's vital HIV programme can proceed.
Broader Context
Zimbabwe's decision follows a similar case in Kenya, where a court suspended a related deal with the US after concerns were filed about the security of citizens' medical information.
Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
As per reports, Sixteen African countries have to date signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to share its biological resources and data for a long time, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our population if a future health crisis emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining systems already set up via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued discussions with our US partners on how subsequent co-operation might be designed in a way that honours the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but suggested that negotiations must proceed given that much of the nation's Aids initiatives depended on international support.
"Where technical issues exist, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it commented.
The situation underscores the complex debate between accepting vital foreign assistance and safeguarding a country's data in an increasingly interconnected world.